WU Yi-long. FDA Alert:Cancer Patients Should Use Erythropoiesis-Stimulating Agent with Caution[J]. Journal of Evidence-Based Medicine, 2007, 7(1): 1-1. DOI: 10.3969/j.issn.1671-5144.2007.01.001
|
Citation:
|
WU Yi-long. FDA Alert:Cancer Patients Should Use Erythropoiesis-Stimulating Agent with Caution[J]. Journal of Evidence-Based Medicine, 2007, 7(1): 1-1. DOI: 10.3969/j.issn.1671-5144.2007.01.001
|
WU Yi-long. FDA Alert:Cancer Patients Should Use Erythropoiesis-Stimulating Agent with Caution[J]. Journal of Evidence-Based Medicine, 2007, 7(1): 1-1. DOI: 10.3969/j.issn.1671-5144.2007.01.001
|
Citation:
|
WU Yi-long. FDA Alert:Cancer Patients Should Use Erythropoiesis-Stimulating Agent with Caution[J]. Journal of Evidence-Based Medicine, 2007, 7(1): 1-1. DOI: 10.3969/j.issn.1671-5144.2007.01.001
|
DownLoad: